GB-115 mechanism of action The gb115 peptide, also known by its chemical name N-(6-phenylhexanoyl)glycyl-L-tryptophan amide and the brand name Ranquilon, is a novel dipeptide compound that has garnered significant attention for its anxiolytic propertiesClinical effects of central antagonist of cholecystokinin-1 .... Developed as a selective antagonist of central cholecystokinin-1 (CCK-1) receptors, GB-115 represents a promising therapeutic agent for various conditions, particularly anxiety disorders.作者：TA Gudasheva·2018·被引用次数：39—GB 115, A SELECTIVE DIPEPTIDE ANXIOLYTIC. The classical strategy “from the endogenouspeptideto the drug” was used for design of selective dipeptide anxiolytic ... Its mechanism of action, distinct from traditional benzodiazepines, offers a potential alternative with a different side-effect profile. Beyond its primary role in anxiety treatment, research has also explored its anti-inflammatory effects and impact on cognitive processes.
GB-115 functions by targeting and blocking the activity of cholecystokinin-1 receptors in the central nervous system. Cholecystokinin (CCK) is a neuropeptide that plays a role in a variety of physiological processes, including satiety, pain perception, and anxiety. By antagonizing CCK-1 receptors, GB-115 is believed to modulate neural pathways associated with fear and stress responses.作者：O Dorofeeva·2022—The impact of a newpeptideantagonist of central cholecystokinin-1 receptors (GB-115) on cognitive processes in patients with GAD is ... This selective action differentiates it from broader-acting anxiolytics, potentially leading to a more targeted therapeutic effect. Studies suggest that its anxiolytic action is accompanied by mild psychostimulant properties, which may contribute to its effectiveness in managing generalized anxiety disorder (GAD)Preclinical and Clinical Pharmacokinetics of a Novel ....
The primary clinical interest in the GB-115 peptide lies in its potential to treat anxiety disorders. Clinical trials have investigated its efficacy and safety in patients suffering from anxiety.GB-115 - Spray Solution (2mg/mL) One notable study focused on its impact on cognitive processes in patients with GAD, suggesting a positive influence beyond just symptom reduction. The development of Ranquilon, the brand name under which GB-115 has been approved in Russia, underscores its progression from preclinical research to clinical applicationSynthesis of substituted dipeptide GB115 as a potential .... Further investigations are ongoing, including studies examining its role in managing anxiety within specific clinical trial contexts.
While anxiety treatment is the most prominent application, the GB-115 peptide has also demonstrated other notable effectsClinical effects of central antagonist of cholecystokinin-1 .... Research has indicated anti-inflammatory properties, with studies showing a significant alleviation of experimental autoimmune encephalomyelitis in mice following intraperitoneal injection of GB-115. This suggests a broader therapeutic scope that could extend to inflammatory and autoimmune conditions.Inhibition of Viral Membrane Fusion by Peptides and ... Furthermore, its influence on emotional stress reactions and the restoration of adaptive behavior in preclinical models has been observed, indicating potential benefits in managing stress-related conditionsStudy of anti-inflammatory effects of GB-115, a glycine- ....
Understanding the pharmacokinetic profile of GB-115 is crucial for its effective clinical use. Studies have evaluated its absorption, distribution, metabolism, and excretion in various species, including rats, rabbits, and human volunteers. Developing precise analytical methods for quantifying the GB-115 peptide in biological media is essential for pharmacokinetic studies and therapeutic drug monitoring. Chromatographic techniques, such as HPLC/MS, have been employed to achieve this quantitative determination, ensuring the accuracy and reliability of research findings.
The GB-115 peptide represents an exciting development in the field of neuropharmacologyGB-115: Uses, Interactions, Mechanism of Action. Its selective mechanism of action as a CCK-1 receptor antagonist offers a novel approach to managing anxiety and potentially other conditions. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential, refine dosing strategies, and further characterize its safety profile. As a dipeptide compound, it also highlights the growing importance of peptide-based therapeutics in modern medicine作者：EV Shipaeva·2008·被引用次数：3—...PeptideFrom Rice: An in Silico and in Vitro Study. Article 20 February 2025. The use of generic surrogatepeptidesfor the quantitative .... The development of efficient synthesis methods for peptides like GB-115 is also an active area of research, aiming to make these potentially life-changing compounds more accessible.
Join the newsletter to receive news, updates, new products and freebies in your inbox.